EP3464336
Efnasambönd
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.6.2017EP published:
16.3.2022EP application number:
17807519.8
EP translation filed:
24.3.2022Grant published:
15.4.2022EPO information:
European Patent Register
Max expiry date:
31.5.2037Expiry date:
31.5.2026Next due date:
30.6.2026
Title in English:
COMPOUNDSLanguage of the patent:
English
Timeline
Today
1.6.2017EP application
16.3.2022EP Publication
24.3.2022Translation submitted
15.4.2022Registration published
31.5.2026Expires
Owner
Name:
Athira Pharma, Inc.Address:
18706 North Creek Parkway, Suite 104, Bothell, WA 98011, US
Inventor
Name:
KAWAS, Leen, H.Address:
Seattle WA 98195, US
Name:
SINGH, JasbirAddress:
Seattle WA 98195, US
Name:
STEWART, Lansing JosephAddress:
Seattle WA 98195, US
Name:
BAKER, William, R.Address:
WA 98195, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662344305 PDate:
1.6.2016Country:
US
Classification
Categories:
C07K 5/065, C07K 5/06, C07K 5/02, C07K 14/475, A61K 38/22, A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 13.6.2022
Expires: 31.5.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 15.6.2023
Expires: 31.5.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 11.6.2024
Expires: 31.5.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 10.6.2025
Expires: 31.5.2026
Payer: G.H. Sigurgeirsson ehf.